A Low Eosinophil to Platelet Ratio as a Worse Prognostic Index for Emergency Department Attendance in Acute Exacerbation of COPD

References

• Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/s0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527
   PubMed Web of Science ®Google Scholar
• Xiong W, Xu M, Zhao Y, et al. Can we predict the prognosis of COPD with a routine blood test? Int J Chron Obstruct Pulmon Dis. 2017;12:615–625. doi:10.2147/COPD.S124041
   PubMed Web of Science ®Google Scholar
• Kumar P, Law S, Sriram KB. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(6):1509–1516. doi:10.21037/jtd.2017.05.77
   PubMed Web of Science ®Google Scholar
• Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–2290. doi:10.2147/COPD.S141760
   PubMed Web of Science ®Google Scholar
• Abidi K, Khoudri I, Belayachi J, et al. Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. Crit Care. 2008;12(2):R59. doi:10.1186/cc6883
   PubMed Web of Science ®Google Scholar
• Holland M, Alkhalil M, Chandromouli S, et al. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease. Respirology. 2010;15(1):165–167. doi:10.1111/j.1440-1843.2009.01651.x
   PubMed Web of Science ®Google Scholar
• Yu S, Zhang J, Fang Q, et al. Blood eosinophil levels and prognosis of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Am J Med Sci. 2021;362(1):56–62. doi:10.1016/j.amjms.2021.02.013
   PubMed Web of Science ®Google Scholar
• MacDonald MI, Osadnik CR, Bulfin L, et al. Low and high blood eosinophil counts as biomarkers in hospitalized acute exacerbations of COPD. Chest. 2019;156(1):92–100. doi:10.1016/j.chest.2019.02.406
   PubMed Web of Science ®Google Scholar
• Chan MC, Yeung YC, Elm Y, et al. Blood eosinophil and risk of exacerbation in chronic obstructive pulmonary disease patients: a retrospective cohort analysis. Int J Chron Obstruct Pulmon Dis. 2020;15:2869–2877. doi:10.2147/COPD.S268018
   PubMed Web of Science ®Google Scholar
• Prins HJ, Duijkers R, Lutter R, et al. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD. Respir Med. 2017;131:118–124. doi:10.1016/j.rmed.2017.07.064
   PubMed Web of Science ®Google Scholar
• Vanderschueren S, De Weerdt A, Malbrain M, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. 2000;28(6):1871–1876.
   PubMed Web of Science ®Google Scholar
• Strauss R, Wehler M, Mehler K, et al. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. 2002;30(8):1765–1771.
   PubMed Web of Science ®Google Scholar
• Stéphan F, Hollande J, Richard O, et al. Thrombocytopenia in a surgical ICU. Chest. 1999;115(5):1363–1370.
   PubMed Web of Science ®Google Scholar
• Lopez-Delgado JC, Rovira A, Esteve F, et al. Thrombocytopenia as a mortality risk factor in acute respiratory failure in H1N1 influenza. Swiss Med Wkly. 2013:143:w13788. doi:10.4414/smw.2013.13788
   PubMed Web of Science ®Google Scholar
• Fawzy A, Anderson JA, Cowans NJ, et al. Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Respir Res. 2019;20(1):86. doi:10.1186/s12931-019-1059-1
   PubMed Web of Science ®Google Scholar
• Harrison MT, Short P, Williamson PA, et al. Thrombocytosis is associated with increased short and long term mortality after exacerbation of chronic obstructive pulmonary disease: a role for antiplatelet therapy? Thorax. 2014;69(7):609–615. doi:10.1136/thoraxjnl-2013-203996
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi:10.1136/thoraxjnl-2012-202103
   PubMed Web of Science ®Google Scholar
• Pascoe S, Locantore N, Dransfield MT, et al. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3(6):435–442. doi:10.1016/S2213-2600(15)00106-X
   PubMed Web of Science ®Google Scholar
• Pavord ID, Chanez P, Criner GJ, et al. Mepolizumab for eosinophilic chronic obstructive pulmonary disease. N Engl J Med. 2017;377(17):1613–1629. doi:10.1056/NEJMoa1708208
   PubMed Web of Science ®Google Scholar
• Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial. Lancet. 2012;380(9842):651–659. doi:10.1016/S0140-6736(12)60988-X
   PubMed Web of Science ®Google Scholar
• Vedel-Krogh S, Nielsen SF, Lange P, et al. Blood eosinophils and exacerbations in chronic obstructive pulmonary disease. the Copenhagen general population study. Am J Respir Crit Care Med. 2016;193(9):965–974. doi:10.1164/rccm.201509-1869OC
   PubMed Web of Science ®Google Scholar
• Lv MY, Qiang LX, Li ZH, et al. The lower the eosinophils, the stronger the inflammatory response? The relationship of different levels of eosinophils with the degree of inflammation in acute exacerbation chronic obstructive pulmonary disease (AECOPD). J Thorac Dis. 2021;13(1):232–243. doi:10.21037/jtd-20-2178
   PubMed Web of Science ®Google Scholar
• Wu H-X, Zhuo K-Q, Cheng D-Y. Peripheral blood eosinophil as a biomarker in outcomes of acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:3003–3015. doi:10.2147/COPD.S226783
   PubMed Web of Science ®Google Scholar
• Prudente R, Ferrari R, Mesquita CB, et al. Peripheral blood eosinophils and Nine years mortality in COPD patients. Int J Chron Obstruct Pulmon Dis. 2021;16:979–985. doi:10.2147/COPD.S265275
   PubMed Web of Science ®Google Scholar
• Bartziokas K, Papathanasiou E, Papaioannou AI, et al. Eosinopenia as a prognostic biomarker for noninvasive ventilation use in COPD exacerbations. J Pers Med. 2023;13(4):686.
   PubMed Web of Science ®Google Scholar
• Rahimi-Rad MH, Soltani S, Rabieepour M, et al. Thrombocytopenia as a marker of outcome in patients with acute exacerbation of chronic obstructive pulmonary disease. Pneumonol Alergol Pol. 2015;83(5):348–351. doi:10.5603/PiAP.2015.0056
   PubMedGoogle Scholar
• Russell R, Beer S, Pavord ID, et al. The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2019;14:971–977. doi:10.2147/COPD.S190085
   PubMed Web of Science ®Google Scholar
• Linch SN, Kelly AM, Danielson ET, et al. Mouse eosinophils possess potent antibacterial properties in vivo. Infect Immun. 2009;77(11):4976–4982. doi:10.1128/IAI.00306-09
   PubMed Web of Science ®Google Scholar
• Rosenberg HF, Dyer KD, Domachowske JB. Respiratory viruses and eosinophils: exploring the connections. Antiviral Res. 2009;83(1):1–9. doi:10.1016/j.antiviral.2009.04.005
   PubMed Web of Science ®Google Scholar
• Handzel ZT, Busse WW, Sedgwick JB, et al. Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol. 1998;160(3):1279–1284.
   PubMed Web of Science ®Google Scholar
• Aksoy E, Güngör S, Ağca MÇ, et al. A revised treatment approach for hospitalized patients with eosinophilic and neutrophilic exacerbations of chronic obstructive pulmonary disease. Turk Thorac J. 2018;19(4):193–200. doi:10.5152/TurkThoracJ.2018.18004
   PubMedGoogle Scholar
• Rahimirad S, Ghaffary MR, Rahimirad MH, et al. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease. Tuberk Toraks. 2017;65(1):25–31.
   PubMed Web of Science ®Google Scholar
• Emami Ardestani M, Alavi-Naeini N. Evaluation of the relationship of neutrophil-to lymphocyte ratio and platelet-to-lymphocyte ratio with in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2021;15(4):382–388. doi:10.1111/crj.13312
   PubMed Web of Science ®Google Scholar
• Chen L, Chen L, Zheng H, et al. Emergency admission parameters for predicting in-hospital mortality in patients with acute exacerbations of chronic obstructive pulmonary disease with hypercapnic respiratory failure. BMC Pulm Med. 2021;21:1.
   PubMed Web of Science ®Google Scholar
• Yang H, Xiang P, Zhang E, et al. Is hypercapnia associated with poor prognosis in chronic obstructive pulmonary disease? A long-term follow-up cohort study. BMJ Open. 2015;5(12):e008909. doi:10.1136/bmjopen-2015-008909
   PubMed Web of Science ®Google Scholar
• Matkovic Z, Huerta A, Soler N, et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respir Int Rev Thoracic Dis. 2012;84(1):17–26. doi:10.1159/000335467
   Google Scholar
• Chen C-W, Chen -Y-Y, C-l L, et al. Severe hypoalbuminemia is a strong independent risk factor for acute respiratory failure in COPD: a nationwide cohort study. Int J Chron Obstruct Pulmon Dis. 2015;10:1147–1154. doi:10.2147/COPD.S85831
   PubMed Web of Science ®Google Scholar
• Lomholt FK, Laulund AS, Bjarnason NH, et al. Meta-analysis of routine blood tests as predictors of mortality in COPD. Eur Clin Respir J. 2014;1. doi:10.3402/ecrj.v1.24110
   PubMedGoogle Scholar